NO990609L - Pyrrolidin- og piperidin-derivater - Google Patents

Pyrrolidin- og piperidin-derivater

Info

Publication number: NO990609L
Authority: NO; Norway
Prior art keywords: pyrrolidine; hydrogen; independently; lower alkoxy; piperidine derivatives
Prior art date: 1998-02-10

Application number

NO990609A

Other languages

English (en)

Norwegian (no)

Other versions

NO990609D0 (no

Inventor

Alexander Alanine

Bernd Buettelmann

Marie-Paule Heitz Neidhart

Emmanuel Pinard

Rene Wyler

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-02-10

Filing date

1999-02-09

Publication date

1999-08-11

1999-02-09 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

1999-02-09 Publication of NO990609D0 publication Critical patent/NO990609D0/no

1999-08-11 Publication of NO990609L publication Critical patent/NO990609L/no

Links

RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 title abstract 6
150000003053 piperidines Chemical class 0.000 title abstract 2
125000003545 alkoxy group Chemical group 0.000 abstract 3
229910052739 hydrogen Inorganic materials 0.000 abstract 3
239000001257 hydrogen Substances 0.000 abstract 3
125000000217 alkyl group Chemical group 0.000 abstract 2
229910052736 halogen Inorganic materials 0.000 abstract 2
150000002367 halogens Chemical class 0.000 abstract 2
150000002431 hydrogen Chemical class 0.000 abstract 2
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
102000004868 N-Methyl-D-Aspartate Receptors Human genes 0.000 abstract 1
108090001041 N-Methyl-D-Aspartate Receptors Proteins 0.000 abstract 1
125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Psychiatry (AREA)
Psychology (AREA)
Vascular Medicine (AREA)
Pain & Pain Management (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Cardiology (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Pyrrole Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

NO990609A 1998-02-10 1999-02-09 Pyrrolidin- og piperidin-derivater NO990609L (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP98102246		1998-02-10

Publications (2)

Publication Number	Publication Date
NO990609D0 NO990609D0 (no)	1999-02-09
NO990609L true NO990609L (no)	1999-08-11

Family

ID=8231382

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO990609A NO990609L (no)	1998-02-10	1999-02-09	Pyrrolidin- og piperidin-derivater

Country Status (28)

Country	Link
US (2)	US6015824A (de)
EP (1)	EP0937458B1 (de)
JP (1)	JP3142527B2 (de)
KR (1)	KR100319249B1 (de)
CN (1)	CN1144789C (de)
AR (1)	AR018077A1 (de)
AT (1)	ATE285766T1 (de)
AU (1)	AU748335B2 (de)
BR (1)	BR9900742A (de)
CA (1)	CA2260698A1 (de)
CZ (1)	CZ41099A3 (de)
DE (1)	DE69922858T2 (de)
DK (1)	DK0937458T3 (de)
ES (1)	ES2245808T3 (de)
HR (1)	HRP990042A2 (de)
HU (1)	HUP9900275A3 (de)
ID (1)	ID23456A (de)
IL (2)	IL128389A0 (de)
MA (1)	MA26607A1 (de)
NO (1)	NO990609L (de)
NZ (1)	NZ334081A (de)
PE (1)	PE20000276A1 (de)
PL (1)	PL331336A1 (de)
PT (1)	PT937458E (de)
SG (1)	SG74120A1 (de)
TR (1)	TR199900286A2 (de)
YU (1)	YU5899A (de)
ZA (1)	ZA991038B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2793245B1 (fr) *	1999-05-05	2002-10-11	Adir	Nouveaux composes pyridiniques ou piperidiniques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US6369078B1 (en) *	1999-08-31	2002-04-09	J. Phillip Bowen	Solenopsin derivatives and analogues as fire ant suppressants
CA2404464C (en)	2000-04-20	2008-03-11	F. Hoffmann-La Roche Ag	Pyrrolidine and piperidine derivatives and their use for the treatment of neurodegenerative disorders
AU2002223968A1 (en)	2000-12-21	2002-07-01	Warner Lambert Company Llc	Piperidine derivatives as subtype selective n-methyl-d-aspartate antagonists
MXPA02002749A (es)	2001-03-27	2002-10-28	Warner Lambert Co	Derivados de ciclohexilamina como antagonistas del subtipo selectivo del n-metil-d-aspartato.
US7005432B2 (en) *	2002-05-16	2006-02-28	Hoffman-La Roche Inc.	Substituted imidazol-pyridazine derivatives
MX2010009649A (es) *	2008-03-27	2010-12-17	Evotecv Neurosciences Gmbh	Metodos para tratar trastornos utilizando un antagonista selectivo del subtipo nr2b de nmda.
CA2770475C (en) *	2009-08-27	2017-06-27	Merck Sharp & Dohme Corp.	Novel pyrrolidine derived beta 3 adrenergic receptor agonists
US8354403B2 (en) *	2009-08-27	2013-01-15	Merck Sharp & Dohme Corp.	Pyrrolidine derived beta 3 adrenergic receptor agonists
GB201714734D0 (en)	2017-09-13	2017-10-25	Atrogi Ab	New compounds and uses
GB201903832D0 (en)	2019-03-20	2019-05-01	Atrogi Ab	New compounds and methods

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3941796A (en) *	1970-05-21	1976-03-02	Minnesota Mining And Manufacturing Company	α-(Hydroxy and alkoxy substituted)phenyl-α-(2-piperidinyl)-methanols
US4407670A (en) *	1980-02-28	1983-10-04	National Research Development Corporation	Biocidal compounds and compositions
US4342692A (en) *	1980-10-20	1982-08-03	Usv Pharmaceutical Corporation	Pyrrolidines
ZA825227B (en) *	1981-07-22	1984-03-28	Syntex Inc	Substituted pyrrolidine cardiovascular system regulators antihypertensives
EP0115413A1 (de) *	1983-01-24	1984-08-08	Syntex (U.S.A.) Inc.	+/- 2-(phenethyl)-5-((3,4-Methylenedioxy)-alpha-hydroxybenzyl)-Pyrrolidine, pharmazeutische Zusammenstellungen die sie enthalten, Verfahren zur Herstellung und deren Zwischenprodukte
IL70752A0 (en) *	1983-01-24	1984-06-29	Syntex Inc	(+-)2-(3,4-methylenedioxyphenethyl)-5-(3-carbamoyl-alpha,4-dihydroxybenzyl)pyrrolidines and salts thereof,their preparation and pharmaceutical compositions containing them
US4569941A (en) *	1983-03-21	1986-02-11	Usv Pharmaceutical Corp.	Method of using phenyl-alkylene-2-pyridyl derivatives to increase cardiac contractility in a mammal
US4548951A (en) *	1983-04-21	1985-10-22	Syntex (U.S.A.) Inc.	Hypotensive benzoxathiole pyrrolidines
US4558066A (en) *	1984-05-17	1985-12-10	Syntex (U.S.A.) Inc.	Treatment and prevention of ocular hypertension
US4632929A (en) *	1985-01-17	1986-12-30	Usv Pharmaceutical Corp.	Method of hypertensive treatment using phenyl-alkylene-2-pyridyl derivatives

1999
- 1999-01-20 US US09/234,266 patent/US6015824A/en not_active Expired - Fee Related
- 1999-02-02 DK DK99102078T patent/DK0937458T3/da active
- 1999-02-02 DE DE69922858T patent/DE69922858T2/de not_active Expired - Fee Related
- 1999-02-02 EP EP99102078A patent/EP0937458B1/de not_active Expired - Lifetime
- 1999-02-02 PT PT99102078T patent/PT937458E/pt unknown
- 1999-02-02 ES ES99102078T patent/ES2245808T3/es not_active Expired - Lifetime
- 1999-02-02 AT AT99102078T patent/ATE285766T1/de not_active IP Right Cessation
- 1999-02-05 IL IL12838999A patent/IL128389A0/xx unknown
- 1999-02-05 BR BR9900742-8A patent/BR9900742A/pt not_active IP Right Cessation
- 1999-02-05 CA CA002260698A patent/CA2260698A1/en not_active Abandoned
- 1999-02-05 NZ NZ334081A patent/NZ334081A/xx unknown
- 1999-02-05 CZ CZ99410A patent/CZ41099A3/cs unknown
- 1999-02-05 MA MA25457A patent/MA26607A1/fr unknown
- 1999-02-06 KR KR1019990004058A patent/KR100319249B1/ko not_active Expired - Fee Related
- 1999-02-08 AU AU16354/99A patent/AU748335B2/en not_active Ceased
- 1999-02-08 JP JP11029850A patent/JP3142527B2/ja not_active Expired - Fee Related
- 1999-02-08 SG SG1999000363A patent/SG74120A1/en unknown
- 1999-02-08 AR ARP990100528A patent/AR018077A1/es unknown
- 1999-02-08 PE PE1999000101A patent/PE20000276A1/es not_active Application Discontinuation
- 1999-02-08 HU HU9900275A patent/HUP9900275A3/hu unknown
- 1999-02-09 HR HR98102246.0A patent/HRP990042A2/hr not_active Application Discontinuation
- 1999-02-09 ZA ZA9901038A patent/ZA991038B/xx unknown
- 1999-02-09 NO NO990609A patent/NO990609L/no not_active Application Discontinuation
- 1999-02-09 PL PL99331336A patent/PL331336A1/xx unknown
- 1999-02-09 ID IDP990095A patent/ID23456A/id unknown
- 1999-02-09 YU YU5899A patent/YU5899A/sh unknown
- 1999-02-10 CN CNB991018001A patent/CN1144789C/zh not_active Expired - Fee Related
- 1999-02-10 TR TR1999/00286A patent/TR199900286A2/xx unknown
- 1999-07-28 US US09/362,932 patent/US6153624A/en not_active Expired - Fee Related
2001
- 2001-07-19 IL IL14445601A patent/IL144456A0/xx unknown

Also Published As

Publication number	Publication date
CN1144789C (zh)	2004-04-07
DE69922858D1 (de)	2005-02-03
CN1232025A (zh)	1999-10-20
PE20000276A1 (es)	2000-04-18
BR9900742A (pt)	2000-05-09
US6015824A (en)	2000-01-18
US6153624A (en)	2000-11-28
NZ334081A (en)	2000-07-28
AR018077A1 (es)	2001-10-31
YU5899A (sh)	2001-07-10
EP0937458A3 (de)	2001-05-23
ZA991038B (en)	1999-08-10
TR199900286A3 (tr)	1999-09-21
NO990609D0 (no)	1999-02-09
HUP9900275A3 (en)	2001-08-28
CA2260698A1 (en)	1999-08-10
AU748335B2 (en)	2002-05-30
KR100319249B1 (ko)	2002-01-05
KR19990072459A (ko)	1999-09-27
MA26607A1 (fr)	2004-12-20
DE69922858T2 (de)	2006-04-13
EP0937458B1 (de)	2004-12-29
ES2245808T3 (es)	2006-01-16
IL128389A0 (en)	2000-01-31
AU1635499A (en)	1999-08-26
PT937458E (pt)	2005-04-29
JP3142527B2 (ja)	2001-03-07
CZ41099A3 (cs)	1999-09-15
IL144456A0 (en)	2002-05-23
DK0937458T3 (da)	2005-05-17
SG74120A1 (en)	2000-07-18
ATE285766T1 (de)	2005-01-15
EP0937458A2 (de)	1999-08-25
PL331336A1 (en)	1999-08-16
ID23456A (id)	2000-04-27
HRP990042A2 (en)	2000-02-29
HUP9900275A2 (hu)	1999-12-28
HU9900275D0 (en)	1999-04-28
JP2000063384A (ja)	2000-02-29
TR199900286A2 (xx)	1999-09-21

Legal Events

Date	Code	Title	Description
2003-10-20	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
MY138352A (en)	2009-05-29	Benzothiazole derivatives
DE60315674D1 (de)	2007-09-27	Neue imidazopyridine und ihre verwendung
DE60305514D1 (de)	2006-06-29	Neue verwendung von benzothiazolderivaten
MXPA04005886A (es)	2004-09-13	Derivados de azaindolilalquilamina como ligandos de 5-hidroxitirptamina-6.
ATE365742T1 (de)	2007-07-15	4-aminothieno(2,3-d) pyrimidin -6-carbonitril- derivative zur verwendung als pde7 inhibitoren
NO20063382L (no)	2006-09-20	Nye kinolinderivater
NO20050851L (no)	2005-03-29	Kaspase-inhibitorer og anvendelser derav
MXPA04003087A (es)	2004-09-06	Derivados de cromano como ligados de 5-hidroxitriptamina-6.
NO963731L (no)	1996-11-06	Behandling av obsessive-kompulsive sykdommer med 5HT2-antagonister
DK0738269T3 (da)	2000-08-28	Piperidinderivater med PAF-antagonistaktivitet
CA2354606A1 (en)	2002-02-03	Azabicycloalkane derivatives and therapeutic uses thereof
NO20052730L (no)	2005-08-23	Aminoalkosyindoler som 5-HT6-reseptorligander for behandling av CNS-lidelser
EP0937458A3 (de)	2001-05-23	Pyrrolidin und Piperidin Derivate
NO975028L (no)	1997-12-30	Piperazinoderivater som neurokininantagonister
ATE239711T1 (de)	2003-05-15	Neue allythiopyridazinderivate und verfahren zu ihrer herstellung
BR0214488A (pt)	2004-10-19	Derivados de benzotiazol
ATE181734T1 (de)	1999-07-15	N-benzoylmethylsubstituierte paroxetinderivate
PT885004E (pt)	2002-08-30	Utilizacao de derivados de 4-fenil-3,6-di-hidro-2h-piridilo como bloqueadores dos subtipos dos receptores nmda
ATE250597T1 (de)	2003-10-15	N-benzolsulfonyl-l-prolin derivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung
ES8705405A1 (es)	1987-05-16	Procedimiento de preparar nuevos derivados morfolinicos
NO965300D0 (no)	1996-12-11	4-(6-fluor-1,2-benzisoksazolyl)-1-piperidinyl-propoksy-kromen-4-on-derivater, deres fremstilling og deres anvendelse i behandlingen av psykose, schizofreni og angst
NO970431L (no)	1997-08-04	Tetrahydroisokinolin-derivater
PT99207A (pt)	1992-09-30	Processo de preparacao de derivados da piperidina e de composicoes farmaceuticas
DK0461012T3 (da)	1994-09-12	Derivater af ((1-arylpyrrolidin-2-yl)methyl)piperazin, fremstillingen heraf og deres terapeutiske anvendelse
ECSP992856A (es)	2000-09-22	Derivados de pirrolidina y piperidina